SES’s O3b mPOWER System Receives Platinum Space Sustainability Rating
2.6.2025 08:50:00 CEST | Business Wire | Press Release
O3b mPOWER, SES’s second-generation medium earth orbit (MEO) system, has been awarded the Platinum badge by the Space Sustainability Rating (SSR) Association. This is the highest possible SSR rating tier, and has been awarded to the O3b mPOWER constellation of 13 high-throughput and low-latency satellites, eight of which are already in orbit.
The O3b mPOWER mission was assessed across all phases: deployment, operations, and end-of-life disposal. The Platinum rating for O3b mPOWER was based on an in-depth analysis of more than 65 parameters, including: satellite count, orbital region, collision avoidance strategies, adherence to recognised design and operational standards, and SES’s overall approach to data sharing and transparency. SES is the second operator to receive a Platinum rating from the SSR, and the sixth to be officially rated.
Rather than evaluating individual satellites in isolation, the SSR assesses the aggregate sustainability impact of the entire constellation and considers how satellites interact, operate collectively, and contribute to the broader space environment. This recognition indicates that the O3b mPOWER constellation demonstrates minimal impact on the orbital environment beyond what is necessary for mission success and reflects SES’s strong commitment to sustainable space operations and adherence to internationally accepted best practices in space sustainability.
Prof. Jean-Paul Kneib, President of the SSR Association, Academic Director of EPFL Space Center and Head of the Laboratory of Astrophysics (LASTRO), said, "The Space Sustainability Rating provides an independent benchmark to encourage transparency among space actors, promote best practices in space missions, and support the long-term preservation of the orbital environment. The Platinum rating awarded to the O3b mPOWER constellation reflects SES’s strong alignment with the SSR’s criteria across the full mission lifecycle. We celebrate this recognition for the O3b mPOWER constellation and SES’s contribution to a safer, more responsible, and resilient satellite ecosystem. As the SSR continues to evolve, it aims to drive positive change across the space sector by highlighting leadership in space sustainability—such as that demonstrated by SES—and to encourage the global space community to make informed, sustainability-focused decisions."
Milton Torres, Chief Technology Officer of SES, said, “For 40 years, SES has been driving responsible best practices and developing new technologies, partnerships and solutions contributing to sustainable space. This Platinum badge not only highlights our leadership in sustainable space operations but also reinforces our commitment to responsible and innovative practices in the space industry, while supporting long-term space sustainability for all spacecraft operators.”
Follow us on:
Twitter | Facebook | YouTube | LinkedIn | Instagram
Read our Blogs >
Visit the Media Gallery >
About SES
SES has a bold vision to deliver amazing experiences everywhere on Earth by distributing the highest quality video content and providing seamless data connectivity services around the world. As a provider of global content and connectivity solutions, SES owns and operates a geosynchronous earth orbit (GEO) fleet and medium earth orbit (MEO) constellation of satellites, offering a combination of global coverage and high-performance services. By using its intelligent, cloud-enabled network, SES delivers high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners around the world. The company is headquartered in Luxembourg and listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com
About the SSR
The Space Sustainability Rating is a voluntary initiative launched by the World Economic Forum in 2016 and developed since 2018 by a consortium of academic and institutional partners including the European Space Agency (ESA), Massachusetts Institute of Technology (MIT), BryceTech, and the University of Texas at Austin. Created in consultation with industry, policy, and academic stakeholders, the SSR encourages responsible behavior in space by evaluating missions against a set of transparent sustainability criteria. The SSR provides a comprehensive framework for assessing the sustainability of space missions, identifying areas for improvement, and offering operators a chance to communicate their sustainability practices through independent, badge-based ratings: Bronze, Silver, Gold, or Platinum. Each SSR rating also includes actionable recommendations to guide operators in enhancing sustainability practices over time. This approach empowers responsible space actors to continuously evolve their mission strategies and set new benchmarks for space stewardship.
For more information visit: https://spacesustainabilityrating.org/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250601131522/en/
Contacts
For further information please contact:
Suzanne Ong
Communications
Tel. +352 710 725 500
suzanne.ong@ses.com
Rayane Maalouf
SSR Communications
contact@ssr.space
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom